天眼查商业履历信息显示，南京麦澜德医疗科技股份有限公司，成立于2013年，位于南京市，是一家以 从事专用设备制造业为主的企业。企业注册资本10000万人民币，实缴资本9999.9999万人民币。公司法 定代表人为杨瑞嘉。 金融界消息 截至2025年8月25日收盘，麦澜德（688273）报收于46.01元，上涨2.95%，换手率10.49%， 成交量3.86万手，成交金额1.76亿元。 资金流向方面，今日主力资金净流入1724.61万元，占比成交额9.8%。其中，超大单净流入550.49万 元、占成交额3.13%，大单净流入1174.12万元、占成交额6.67%，中单净流出流入702.30万元、占成交 额3.99%，小单净流出2426.91万元、占成交额13.79%。 麦澜德最新一期业绩显示，截至2025一季报，公司营业总收入1.18亿元、同比增长13.36%，归属净利润 3985.97万元，同比增长9.85%，扣非净利润3758.20万元，同比增长11.60%，流动比率9.110、速动比率 8.466、资产负债率9.13%。 通过天眼查大数据分析，南京麦澜德医疗科技股份有限公司共对外投资了17家企业，参与招投 ...

Group 1 - The latest stock price of Mylande is 47.28 yuan, down 1.27% from the previous trading day, with an opening price of 48.00 yuan and a trading range between 46.20 yuan and 48.00 yuan, achieving a transaction amount of 264 million yuan [1] - Mylande is primarily engaged in the research and production of medical devices, focusing on women's health. The company has recently ventured into the AI medical field, beginning trials of the DeepSeek multimodal data fusion technology to create an intelligent diagnostic and treatment closed-loop system [1] - Mylande is exploring the application of artificial intelligence in the medical sector by deploying the DeepSeek system, aiming to construct an intelligent diagnostic solution that covers the entire process of prevention, diagnosis, treatment, and rehabilitation, achieving precise matching of clinical pathways across departments [1] Group 2 - Capital flow data indicates that Mylande experienced a net outflow of 31.24 million yuan on the day, accounting for 1.79% of its circulating market value. Over the past five trading days, the cumulative net outflow reached 39.11 million yuan, representing 2.25% of its circulating market value [1]

Group 1 - The core point of the article highlights the financing activities of the company 麦澜德, indicating a net selling position in the recent trading days [1] - On August 15, 麦澜德 had a financing buy amount of 0.72 billion yuan, ranking 365th in the market, with a financing repayment amount of 0.78 billion yuan, resulting in a net sell of 5.55 million yuan [1] - Over the last three trading days (August 13-15), 麦澜德 experienced financing buys of 0.69 billion yuan, 0.85 billion yuan, and 0.72 billion yuan respectively [1] Group 2 - On August 15, the company had no shares sold short, indicating no net selling in the short selling segment [1]

证券代码：688273 证券简称：麦澜德 公告编号：2025-029 南京麦澜德医疗科技股份有限公司 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 高级管理人员持有股份的基本情况 截至本公告披露日，南京麦澜德医疗科技股份有限公司（以下简称"公司"） 副总经理、董事会秘书陈江宁女士直接持有公司股份 1,039,261 股，占公司总股 本的 1.0393%。前述股份来源于公司首次公开发行前持有的股份，且已于 2024 年 2 月 19 日解除限售并上市流通。 ? 减持计划的主要内容 公司近日收到陈江宁女士出具的《股份减持计划告知函》，因个人资金需求， 陈江宁女士计划自本公告披露日起 15 个交易日后的 3 个月内，在符合法律法规 的前提下，拟通过集中竞价、大宗交易的方式减持所持有的公司股份，合计不超 过 259,815 股，占公司总股本的比例不超过 0.26%。 上述股份的减持价格按照市场价格确定，若公司在上述减持计划实施期间发 生送红股、转增股本、增发新股或配股等除权除息事项的，则上述减持计 ...

2024年1至12月份，麦澜德的营业收入构成为：医疗器械占比69.32%，其他占比29.23%，其他业务占比 1.45%。 麦澜德（SH 688273，收盘价：51.64元）8月14日晚间发布公告称，截至本公告披露日，南京麦澜德医 疗科技股份有限公司副总经理、董事会秘书陈江宁女士直接持有公司股份约104万股，占公司总股本的 1.0393%。前述股份来源于公司首次公开发行前持有的股份，且已于2024年2月19日解除限售并上市流 通。 公司近日收到陈江宁女士出具的《股份减持计划告知函》，因个人资金需求，陈江宁女士计划自本公告 披露日起15个交易日后的3个月内，在符合法律法规的前提下，拟通过集中竞价、大宗交易的方式减持 所持有的公司股份，合计不超过约26万股，占公司总股本的比例不超过0.26%。 （文章来源：每日经济新闻） ...

证券代码：688273 证券简称：麦澜德 公告编号：2025-029 南京麦澜德医疗科技股份有限公司 高级管理人员减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 高级管理人员持有股份的基本情况 截至本公告披露日，南京麦澜德医疗科技股份有限公司（以下简称"公司"） 副总经理、董事会秘书陈江宁女士直接持有公司股份 1,039,261 股，占公司总股 本的 1.0393%。前述股份来源于公司首次公开发行前持有的股份，且已于 2024 年 2 月 19 日解除限售并上市流通。 减持计划的主要内容 公司近日收到陈江宁女士出具的《股份减持计划告知函》，因个人资金需求， 陈江宁女士计划自本公告披露日起 15 个交易日后的 3 个月内，在符合法律法规 的前提下，拟通过集中竞价、大宗交易的方式减持所持有的公司股份，合计不超 过 259,815 股，占公司总股本的比例不超过 0.26%。 上述股份的减持价格按照市场价格确定，若公司在上述减持计划实施期间发 生送红股、转增股本、增发新股或配股等除权除 ...

格隆汇8月14日丨麦澜德(688273.SH)公布，公司近日收到陈江宁女士出具的《股份减持计划告知函》， 因个人资金需求，陈江宁女士计划自本公告披露日起15个交易日后的3个月内，在符合法律法规的前提 下，拟通过集中竞价、大宗交易的方式减持所持有的公司股份，合计不超过25.98万股，占公司总股本 的比例不超过0.26%。上述股份的减持价格按照市场价格确定。 ...

人民财讯8月14日电，麦澜德(688273)8月14日晚间公告，公司副总经理、董事会秘书陈江宁计划通过集 中竞价、大宗交易的方式，减持公司股份合计不超过25.98万股，占公司总股本的比例不超过0.26%。 ...

Market Performance - The Sci-Tech 50 Index rose by 0.75%, closing at 1085.74 points, with a total trading volume of 5.17 billion shares and a turnover of 217.99 billion yuan, resulting in an average turnover rate of 2.81% [1] - Among the tradable stocks on the Sci-Tech board, 73 stocks closed higher, with 6 stocks rising over 10%, including Fangke Technology and Botao Biology, which hit the daily limit [1] - The turnover rate distribution shows that 7 stocks had a turnover rate exceeding 20%, while 24 stocks had a turnover rate between 10% and 20% [1] Stock Highlights - Longtu Guangzhao had the highest turnover rate at 36.92%, closing up by 12.98% with a transaction amount of 712 million yuan [1] - Jin Chengzi closed down by 9.88% with a turnover rate of 31.87%, and a transaction amount of 403 million yuan [1] - Other notable stocks with high turnover rates include Mailan De and Zhongyou Technology, with turnover rates of 29.46% and 26.88% respectively [1] Sector Analysis - In the high turnover stocks, the electronics sector had the most representation with 54 stocks, followed by the computer and pharmaceutical sectors with 22 and 21 stocks respectively [2] - The stocks with the highest net inflow of funds included Sainuo Medical, Fangke Technology, and Longtu Guangzhao, with net inflows of 147 million yuan, 83.83 million yuan, and 78.31 million yuan respectively [2] Financial Performance - Among the high turnover stocks, Shijia Photon, Zhenlei Technology, and Dingtong Technology reported significant net profit growth of 1712.00%, 1006.99%, and 134.06% respectively [3] - Tiande Yu reported a net profit growth of 50.89% in its half-year performance report [3] Trading Data - The trading data for high turnover stocks on August 14 includes Longtu Guangzhao with a closing price of 53.72 yuan and a daily increase of 12.98% [3] - Other stocks such as Fangke Technology and Sainuo Medical also showed significant daily increases of 20.01% and 3.05% respectively [4]

Industry Overview - On August 14, the medical device industry experienced a decline of 2.45% with a net outflow of 1.74 billion yuan in principal funds [1] - Among the component stocks, 13 increased while 87 decreased [1] Major Fund Outflows - The companies with the highest net outflows of principal funds included: - Kehua Bio (29.96 million yuan) - Baolait (29.32 million yuan) - Shangrong Medical (28.74 million yuan) - Weisi Medical (26.93 million yuan) - ST Kelly (26.25 million yuan) [1] Notable Stock Performance - Key stocks with significant movements included: - Sainuo Medical: Latest price 30.43, up 3.05%, with a net inflow of 164 million yuan (7.25% of total) [1] - Botao Bio: Latest price 45.13, up 19.99%, with a net inflow of 543.74 thousand yuan (12.47% of total) [1] - Yuyue Medical: Latest price 35.67, down 0.17%, with a net inflow of 49.30 thousand yuan (12.91% of total) [1] - Kefu Medical: Latest price 40.58, up 6.99%, with a net inflow of 470.40 thousand yuan (14.3% of total) [1] - Huatai Medical: Latest price 290.99, down 2.03%, with a net inflow of 297.47 thousand yuan (9.99% of total) [1] - Aohua Endoscopy: Latest price 49.14, down 7.79%, with a net inflow of 2363.53 thousand yuan (10.09% of total) [1] - Meihua Medical: Latest price 20.94, up 3.05%, with a net inflow of 2316.72 thousand yuan (4.81% of total) [1] - Wanfu Bio: Latest price 24.28, down 0.92%, with a net inflow of 184.26 thousand yuan (5.48% of total) [1] - Zhijiang Bio: Latest price 25.24, up 4.87%, with a net inflow of 1420.31 thousand yuan (5.07% of total) [1] - Mairande: Latest price 51.64, up 1.06%, with a net inflow of 1335.64 thousand yuan (2.42% of total) [1]